secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001493152-23-024726
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals dismisses Buchbinder, appoints Mazers as new auditor
--------------------------------------------------------------------------

- Audit Committee approved appointment of Mazers USA LLP on July 11, 2023, effective same day.
- Buchbinder Tunick & Company LLP was dismissed as independent auditor, effective July 12, 2023.
- No disagreements or reportable events with Buchbinder during fiscal years 2022 and 2023 or subsequent interim period.
- Buchbinder's reports for those fiscal years contained no adverse opinion or qualification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/0001493152-23-024726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223024726/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer